Detalhe da pesquisa
1.
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.
Ann Oncol
; 31(7): 921-929, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294529
2.
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Ann Oncol
; 29(1): 133-138, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045659
3.
Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial.
Ann Oncol
; 26(6): 1208-1215, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25739671
4.
Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929.
Ann Oncol
; 31(9): 1276, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653357
5.
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.
Ann Oncol
; 26(2): 340-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403578
6.
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne / Pays de la Loire).
Oncologie (Paris)
; 16(5): 267-276, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-26190928
7.
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Ann Oncol
; 29(11): 2270, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718089
8.
Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study.
Endoscopy
; 44(11): 998-1008, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23108771
9.
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.
Br J Cancer
; 102(1): 59-67, 2010 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19920832
10.
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.
Ann Oncol
; 26(5): 1040, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25900678
11.
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6.
Oncology
; 79(3-4): 174-80, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21358204
12.
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer.
PLoS One
; 15(12): e0243997, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33347495
13.
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.
Eur J Cancer
; 97: 16-24, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29777975
14.
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
J Clin Oncol
; 23(15): 3509-16, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15908661
15.
[Black esophagus. Three new cases]. / L'oesophage noir. Trois nouveaux cas.
Gastroenterol Clin Biol
; 17(4): 298-301, 1993.
Artigo
em Francês
| MEDLINE | ID: mdl-8339891
16.
[Multicenter prospective study of prognostic factors of gastroduodenal ulcer hemorrhages. Reevaluation of clinical and endoscopic factors in the era of endoscopic hemostasis]. / Etude prospective multicentrique des facteurs pronostiques des hémorragies ulcéreuses gastroduodénales. Réévaluation des facteurs cliniques et endoscopiques à l'ère de l'hémostase endoscopique.
Gastroenterol Clin Biol
; 24(2): 193-200, 2000 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-12687961
17.
[Ischemic colitis after taking flutamide]. / Colite ischémique après prise de flutamide.
Gastroenterol Clin Biol
; 22(10): 841, 1998 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-9854217
18.
[Treatment of external pancreatic fistula by depot somatostatin]. / Traitement d'une fistule pancréatique externe par la somatostatine retard.
Presse Med
; 16(28): 1379, 1987.
Artigo
em Francês
| MEDLINE | ID: mdl-2888105
19.
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer.
Br J Cancer
; 97(3): 297-301, 2007 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-17637682
20.
[Surgical treatment of chronic pancreatitis. Indications and results. An experience of 246 cases]. / Traitement chirurgical de la pancréatite chronique. Indications et résultats--Expérience de 246 cas.
Chirurgie
; 115(2): 123-31; discussion 132, 1989.
Artigo
em Francês
| MEDLINE | ID: mdl-2805920